首页> 外国专利> 18 - 19 nor androst - methyl - 4 - 17 espiroeteres (17 - 18 - 19 20 - nor - methyl - 4 - 3 - espirox ones) as well as Preparations Containing Pharmaceuticals

18 - 19 nor androst - methyl - 4 - 17 espiroeteres (17 - 18 - 19 20 - nor - methyl - 4 - 3 - espirox ones) as well as Preparations Containing Pharmaceuticals

机译:18-19个非雄甾烷-甲基-4-17个灵芝菌(17-18-19个20个正甲-甲基-4-3个灵芝菌)以及含有药物的制剂

摘要

1. - 18-methyl-15 Di,16 di-methyl-19-nor-20-helix-4-en-3-onas general formula I-I en dondez is an oxygen atom, two hydrogen atoms, a group = nor or nnhso2r, where R is a hydrogen atom, or a linear or separator group, 1-4 or 3-4 carbon atoms, and R4 is a hydrogen atom, A halogen atom or a trifluoroethylene group, and R6 and / or R7 may be in a or a position,R6 and R7 are independent,Hydrogen atom or linear or separable chain coke group, 1 to 4, or 3 to 4 carbon atoms, or 2 to 4 linear or separable chain groups, or 3 to 4 carbon atoms, or 3 to 4 carbon atoms, or 3 to 5 carbon atoms saturated cyclododecane group, or both have a methylene group or two bonds. 2. - 18-methyl-15 Di,16-methyl-19-nor-20-helix-4-en-3-onas, general formula I, is characterized by that z is an oxygen atom. 3. - 18-methyl-15 Di,16-methyl-19-nor-20-helix-4-en-3-onas of the general form I is characterized by hydrogen atom, methyl group or chlorine atom. 4. - 18-methyl-15,16-methyl-19-nor-20-helix-4-en-3-onas, general formula I, characterized by R6 and R7 being a 5A, 6a or 5B group,Or add a link. 5. - 18-methyl-15 Di,16-methyl-19-nor-20-helix-4-en-3-onas, general formula I, characterized by R7 being a-o-methyl -,Ethyl.Propylene or the residue of etenero or a-o-cyclopapile.
机译:1.-18-甲基-15 Di,16 di-methyl-19-nor-20-helix-4-en-3-onas通式II en dondez是一个氧原子,两个氢原子,一个基团= nor或nnhso2r ,其中R是氢原子,或线性或分隔基,1-4或3-4个碳原子,并且R4是氢原子,卤素原子或三氟乙烯基,并且R6和/或R7可以在或位置,R 6和R 7是独立的,氢原子或直链或可分离的链状焦基,1-4,或3-4个碳原子,或2-4个直链或可分离的链基,或3-4个碳原子或3碳原子数为4〜1,或饱和碳原子数为3〜5的环十二烷基,或两者均具有亚甲基或两个键。 2.通式I的18-甲基-15Di,16-甲基-19-nor-20-螺旋-4-en-3-onas的特征在于z是氧原子。 3.-一般形式I的18-甲基-15二,16-甲基-19-nor-20-螺旋-4-en-3-onas的特征在于氢原子,甲基或氯原子。 4.-18-甲基-15,16-甲基-19-nor-20-螺旋-4-en-3-onas,通式I,特征在于R6和R7为5A,6a或5B基团,或添加一个链接。 5.-18-甲基-15 Di,16-甲基-19-nor-20-螺旋-4-en-3-onas,通式I,其特征在于,R7为α-甲基,乙基,丙烯或丙烯酰胺的残基。 etenero或ao-cyclopapile。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号